1. Reduction of obstruction related bladder overactivity by the guanylyl cyclase modulators BAY 41‐2272 and BAY 60‐2770 alone or in combination with a phosphodiesterase type 5 inhibitor. Issue 8 (17th September 2014) Authors: Füllhase, C.; Hennenberg, M.; Sandner, P.; Strittmatter, F.; Niedworok, C.; Bauer, R.M.; Gratzke, C.; Soler, R.; Stief, C.; Andersson, K.E. Journal: Neurourology and urodynamics Issue: Volume 34:Issue 8(2015:Nov.) Page Start: 787 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗